Drug recall D-0298-2020
Product
Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-8
Reason for recall
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Lots and codes
Lot #: K779030125, Exp 10/19; D873031376, Exp 3/20; J871233188, Exp 9/20; L866934047, Exp 11/20; A973134376, 12/20; D967635229, Exp 3/21
Recall details
- Recalling firm
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Quantity
- 138,886 bottles
- Distribution
- U.S.A. Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 27, 2019
- Terminated
- August 31, 2023
Related products
- Ibuprofen – drug information
- NDC 51672-1385 Ibuprofen · Ibuprofen 100 mg/5mL · Sun Pharmaceutical Industries, Inc.